Nov 27, 2024· Comment from Association for Accessible Medicines (AAM)· FDA-2024-N-3653-0003
FDA, Please find attached comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA-2024-N-3653 "Promotion of Prescription Drugs Within a Talk Show Format" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs, on behalf of the Biosimilars Council, AAM